Advertisement
The TJX Companies, Inc.

TJX News Today: Stay Updated with the Latest The TJX Companies, Inc. News in Real Time

Find TJX news now at Meyka AI. Stay informed with the latest{" "} The TJX Companies, Inc. stocks updates, including price news, market analysis, and expert insights.

TJXNYSE
Consumer CyclicalApparel - Retail
$159.78
$0.93(0.58%)
U.S. Market opens in 17h 17m
Advertisement
Nikkei 225 Plunges 3.85% to 64,024.6 on Tech Rout, June 08
📅 in about 2 hours

Nikkei 225 Plunges 3.85% to 64,024.6 on Tech Rout, June 08

Nikkei 225 drops 3.85% to 64,024.6 on June 8 as chip stocks fall, U.S. rate hike fears mount, and Middle East tensions spike oil prices.

Read more 12
Singapore White-Collar Job Losses Rise as Unions Handle 3,900 Cases, June 09
📅 in about 1 hour

Singapore White-Collar Job Losses Rise as Unions Handle 3,900 Cases, June 09

Singapore white-collar retrenchments hit 3,900 in 2025. NTUC warns of AI and offshoring job cuts in finance, tech, and professional services.

Read more 12
MDAX Falls 0.71% on Rate Hike Fears and Tech Weakness, June 08
📅 1 minute ago

MDAX Falls 0.71% on Rate Hike Fears and Tech Weakness, June 08

MDAX drops 0.71% to 32,235 points on June 08 as rate hike fears and tech weakness pressure German mid-cap stocks.

Read more 12
BP Shares Fall 12% to £5.46 as Oil Peace Deal Weighs, June 08
📅 31 minutes ago

BP Shares Fall 12% to £5.46 as Oil Peace Deal Weighs, June 08

BP shares fall 12% to £5.46 on Iran peace deal expectations. JPMorgan holds 600p target; analyst consensus at 635p. CEO change supports oil focus.

Read more 12
Murata Stock Drops 12% on Tech Selloff, June 08
📅 40 minutes ago

Murata Stock Drops 12% on Tech Selloff, June 08

Murata Manufacturing stock fell 12% to ¥8,711 on June 08 amid AI concerns and Middle East tensions. Meyka rates it B.

Read more 12
Eli Lilly Stock (LLY) Jumps 4% to $1,131.42 USD as Retatrutide Cuts Sleep Apnea by 60% in Phase 3 Trial
📅 1 hour ago

Eli Lilly Stock (LLY) Jumps 4% to $1,131.42 USD as Retatrutide Cuts Sleep Apnea by 60% in Phase 3 Trial

Eli Lilly stock gained approximately 4 percent and climbed to $1,131.42 USD after the company announced promising Phase 3 clinical trial results for Retatrutide. The experimental drug demonstrated a remarkable ability to reduce obstructive sleep apnea severity by nearly 60 percent, generating excitement among investors and healthcare professionals. The announcement strengthened confidence in Eli Lilly’s…

Read more 12
S&P 500 Hits AI-Driven Highs as Citigroup Lifts Forecast to 8,100 but Warns on P/E Pressure
📅 1 hour ago

S&P 500 Hits AI-Driven Highs as Citigroup Lifts Forecast to 8,100 but Warns on P/E Pressure

The S&P 500 continues to push toward record territory as enthusiasm surrounding artificial intelligence drives investor confidence across the stock market. Adding to the bullish sentiment, Citigroup recently raised its forecast for the benchmark index to 8,100, reflecting expectations of continued earnings growth and sustained momentum from technology leaders. However, alongside this optimistic outlook, Citigroup…

Read more 12
Meta Stock Falls 5.5% as Massive AI Funding Plan Emerges, June 08
📅 2 hours ago

Meta Stock Falls 5.5% as Massive AI Funding Plan Emerges, June 08

Meta stock drops 5.5% to $593.00 on report of potential tens-of-billions stock offering to fund AI infrastructure expansion and data centers.

Read more 12
MSTR Stock Falls 6.90% to $120.44 as Strategy Inc Class A Drops $8.93 Amid Market Pressure
📅 2 hours ago

MSTR Stock Falls 6.90% to $120.44 as Strategy Inc Class A Drops $8.93 Amid Market Pressure

MSTR Stock experienced a notable decline of 6.90 percent, falling to $120.44 as Strategy Inc Class A shares dropped by $8.93 during a broader wave of market pressure. The move attracted attention across the stock market, especially among investors tracking Bitcoin-linked equities and high-volatility growth names. Strategy Inc, formerly MicroStrategy, is widely known for its…

Read more 12

TJX News FAQ